EUVIMEDEUVIMED entdecken
Crossref

BIOMARKERS OF ANEMIC RETINOPATHY: CURRENT OPPORTUNITIES AND PERSPECTIVES

Sergey Yanchenko, Guljamol Odilova, Nigora Saidova

Scientific and Innovative Therapy · 2025

DOI: 10.64582/ivit.uz.250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific and Innovative Therapy, 2025. Verfasst von Sergey Yanchenko und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anemic retinopathy (AR) occurs in various types of anemia such as iron deficiency, β-thalassemia, and aplastic anemia. Although patients with AR often lack obvious visual complaints, optical coherence tomography (OCT) and OCT angiography (OCTA) can detect early morphometric and functional retinal changes. This article reviews the diagnostic and prognostic value of AR biomarkers and discusses the perspectives of early detection and monitoring.

Zitieren

APA

Yanchenko, S., Odilova, G., & Saidova, N. (2025). BIOMARKERS OF ANEMIC RETINOPATHY: CURRENT OPPORTUNITIES AND PERSPECTIVES. Scientific and Innovative Therapy. https://doi.org/10.64582/ivit.uz.250

Vancouver

Yanchenko S, Odilova G, Saidova N. BIOMARKERS OF ANEMIC RETINOPATHY: CURRENT OPPORTUNITIES AND PERSPECTIVES. Scientific and Innovative Therapy. 2025. doi:10.64582/ivit.uz.250

BibTeX
@article{Yanchenko2025,
  author = {Yanchenko, Sergey and Odilova, Guljamol and Saidova, Nigora},
  title = {BIOMARKERS OF ANEMIC RETINOPATHY: CURRENT OPPORTUNITIES AND PERSPECTIVES},
  journal = {Scientific and Innovative Therapy},
  year = {2025},
  doi = {10.64582/ivit.uz.250}
}
Kostenlos starten →